Capital Counsel’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236M Sell
797,692
-6,651
-0.8% -$1.98M 10.02% 5
2025
Q4
$220M Buy
804,343
+12,606
+2% +$3.43M 8.39% 6
2025
Q3
$214M Sell
791,737
-20,969
-3% -$5.71M 8.2% 7
2025
Q2
$224M Sell
812,706
-7,242
-0.9% -$1.97M 9.09% 7
2025
Q1
$218M Sell
819,948
-5,612
-0.7% -$1.38M 9.64% 3
2024
Q4
$192M Sell
825,560
-3,764
-0.5% -$866K 8.19% 7
2024
Q3
$183M Buy
829,324
+3,986
+0.5% +$825K 7.87% 9
2024
Q2
$162M Buy
825,338
+4,579
+0.6% +$946K 7.24% 9
2024
Q1
$177M Buy
820,759
+36,164
+5% +$7.6M 8.12% 7
2023
Q4
$165M Sell
784,595
-1,426
-0.2% -$304K 8.12% 7
2023
Q3
$157M Buy
786,021
+5,914
+0.8% +$1.18M 8.76% 8
2023
Q2
$145M Buy
780,107
+5,584
+0.7% +$1.03M 7.96% 8
2023
Q1
$148M Sell
774,523
-15,263
-2% -$2.76M 8.53% 7
2022
Q4
$133M Buy
789,786
+36,576
+5% +$6.36M 8.36% 6
2022
Q3
$133M Buy
753,210
+9,621
+1% +$1.9M 8.63% 7
2022
Q2
$152M Sell
743,589
-373
-0.1% -$79.1K 9.28% 6
2022
Q1
$177M Buy
743,962
+841
+0.1% +$198K 8.41% 6
2021
Q4
$170M Sell
743,121
-1,506
-0.2% -$331K 7.19% 7
2021
Q3
$144M Sell
744,627
-5,022
-0.7% -$1.02M 7.09% 7
2021
Q2
$159M Buy
749,649
+22,928
+3% +$4.84M 8.01% 5
2021
Q1
$148M Sell
726,721
-1,250
-0.2% -$246K 8.27% 5
2020
Q4
$133M Sell
727,971
-33,570
-4% -$5.71M 7.76% 5
2020
Q3
$127M Sell
761,541
-2,447
-0.3% -$412K 8.61% 5
2020
Q2
$124M Sell
763,988
-25,767
-3% -$4.62M 9.02% 4
2020
Q1
$137M Sell
789,755
-99,839
-11% -$19.9M 10.86% 3
2019
Q4
$179M Sell
889,594
-10,817
-1% -$2.22M 11.86% 1
2019
Q3
$190M Buy
900,411
+15,201
+2% +$3.18M 13.32% 1
2019
Q2
$172M Sell
885,210
-4,350
-0.5% -$802K 11.51% 3
2019
Q1
$146M Buy
889,560
+4,391
+0.5% +$776K 10.7% 3
2018
Q4
$167M Sell
885,169
-9,455
-1% -$1.75M 13.81% 1
2018
Q3
$152M Sell
894,624
-1,985
-0.2% -$334K 10.62% 2
2018
Q2
$147M Sell
896,609
-2,832
-0.3% -$463K 11.22% 2
2018
Q1
$145M Buy
899,441
+1,690
+0.2% +$269K 11.77% 1
2017
Q4
$131M Sell
897,751
-2,002
-0.2% -$285K 10.78% 2
2017
Q3
$122M Sell
899,753
-5,570
-0.6% -$704K 10.93% 2
2017
Q2
$113M Buy
905,323
+18,628
+2% +$2.23M 10.33% 3
2017
Q1
$105M Buy
886,695
+1,070
+0.1% +$129K 10.03% 3
2016
Q4
$102M Buy
885,625
+3,208
+0.4% +$357K 10.56% 1
2016
Q3
$92.2M Sell
882,417
-8,124
-0.9% -$848K 8.23% 4
2016
Q2
$86.7M Sell
890,541
-31,353
-3% -$2.96M 8% 5
2016
Q1
$88.5M Sell
921,894
-13,489
-1% -$1.23M 8.01% 5
2015
Q4
$84.7M Sell
935,383
-18,236
-2% -$1.72M 4.5% 9
2015
Q3
$88.4M Sell
953,619
-3,168
-0.3% -$301K 4.62% 9
2015
Q2
$89M Buy
956,787
+20,226
+2% +$1.89M 4.41% 10
2015
Q1
$88.7M Sell
936,561
-7,535
-0.8% -$698K 4.23% 10
2014
Q4
$83.7M Sell
944,096
-16,925
-2% -$1.43M 3.93% 11
2014
Q3
$76.8M Sell
961,021
-74,717
-7% -$5.63M 4.32% 11
2014
Q2
$73.5M Buy
1,035,738
+6,145
+0.6% +$433K 4.01% 13
2014
Q1
$76.2M Buy
1,029,593
+44,219
+4% +$3.34M 4.16% 12
2013
Q4
$77.3M Sell
985,374
-28,633
-3% -$2.24M 4.33% 11
2013
Q3
$74.9M Buy
1,014,007
+64,622
+7% +$4.76M 4.36% 11
2013
Q2
$72.1M Buy
+949,385
New +$62.3M 4.32% 9

Other funds holding CME

Capital Counsel's CME Position: Q1 2026 in Review

Capital Counsel reduced its CME Group (CME) stake by 0.83% in Q1 2026, selling an estimated $1.98M and leaving 797,692 shares worth $236M. The position accounts for 10.02% of the portfolio, ranked #5.

Capital Counsel first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Capital Counsel held 797,692 shares of CME Group worth $236M as of Q1 2026.
  • Capital Counsel sold 6,651 CME Group shares in Q1 2026, an estimated $1.98M.
  • CME Group made up 10.02% of Capital Counsel's portfolio in Q1 2026, its #5 holding.
  • Capital Counsel first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Capital Counsel's 13F filing for Q1 2026, filed 15 May 2026.